| Value | ₹367.0 Cr |
|---|
BSE filing, NSE: WELCURE. Summary written from the filing by ALFA Finder's alert engine.
Welcure Drugs & Pharmaceuticals Ltd: key numbers
- Share price
- ₹0.19
- Market cap
- ₹23.48 Cr
- Revenue (annual)
- ₹365.5 Cr
- Net profit (annual)
- ₹-5.49 Cr
- P/E (TTM)
- -1.4×Sector 46.1×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Welcure Drugs & Pharmaceuticals Ltd
All →Welcure Drugs & Pharmaceuticals Board Meeting Outcome
Welcure Drugs & Pharmaceuticals approved the closure of its Ahmedabad corporate office. Operations will continue uninterrupted with records transferred to the registered office.
Welcure Drugs & Pharmaceuticals Other Announcement
Welcure Drugs submitted its Annual Secretarial Compliance Report for FY2026 under Regulation 24A. The report confirms overall compliance while noting historical fines paid for earlier procedural delays.
Welcure Drugs & Pharmaceuticals Q4 FY26 Results: Net Loss of ₹49.9 Cr
Welcure Drugs & Pharmaceuticals Ltd reported a net loss of ₹49.9 Cr for Q4 FY26.
- Key figure
- Net loss ₹49.9 Cr
Welcure Drugs & Pharmaceuticals Board Meeting Date
Welcure Drugs scheduled a board meeting for May 29, 2026. Directors will consider and approve audited financial results for the 2026 fiscal year.
Welcure Drugs & Pharmaceuticals Debt & Borrowing
Welcure Drugs & Pharmaceuticals Ltd confirmed it does not meet SEBI's 'Large Corporate' criteria for the financial year ended March 31, 2026. Consequently, the company is exempt from mandatory incremental borrowing through debt securities. Its outstanding borrowings as of the reporting date were nil.
Welcure Drugs & Pharmaceuticals Other Announcement
Welcure Drugs & Pharmaceuticals Ltd submitted its Regulation 74(5) certificate for the quarter and year ended March 31, 2026. The registrar, Skyline Financial Services, confirmed that no physical share certificates were received for dematerialization during this period. This is a routine regulatory disclosure with no impact on business operations.
Other financial results announcements
All →Vaibhav Global Q2 FY27 Results: Net Profit ₹41.7 Cr, Down 12.4% YoY
Vaibhav Global Ltd reported revenue from operations of ₹938.4 Cr (+7.0% YoY) and net profit of ₹41.7 Cr (-12.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹41.7 Cr · -12.4% YoY
MosChip Technologies Q2 FY27 Results: Net Loss of ₹30.4 Cr
MosChip Technologies Ltd reported revenue from operations of ₹119.1 Cr (-18.9% YoY) and a net loss of ₹30.4 Cr for Q2 FY27.
- Key figure
- Net loss ₹30.4 Cr
OnMobile Global Q2 FY27 Results: Net Loss of ₹10.5 Cr
OnMobile Global Ltd reported revenue from operations of ₹127.1 Cr (-0.9% YoY) and a net loss of ₹10.5 Cr for Q2 FY27.
- Key figure
- Net loss ₹10.5 Cr
Zensar Technologies Q2 FY27 Results: Net Profit ₹190.2 Cr, Up 4.4% YoY
Zensar Technologies Ltd reported revenue from operations of ₹1,585 Cr (+11.5% YoY) and net profit of ₹190.2 Cr (+4.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹190.2 Cr · +4.4% YoY
GMR Airports Q2 FY27 Results: Net Profit ₹65.4 Cr, Up 86.3% YoY
GMR Airports Ltd reported revenue from operations of ₹4,095 Cr (+11.6% YoY) and net profit of ₹65.4 Cr (+86.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹65.4 Cr · +86.3% YoY
Hexaware Technologies Q2 FY27 Results: Net Profit ₹429.4 Cr, Up 16.1% YoY
Hexaware Technologies Ltd reported revenue from operations of ₹3,933 Cr (+12.9% YoY) and net profit of ₹429.4 Cr (+16.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹429.4 Cr · +16.1% YoY